New scan could reveal hidden cancer in High-Risk prostate patients
NCT ID NCT07608419
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study involves 400 men with high-risk prostate cancer who have not yet received treatment. Researchers are using a special type of scan called PSMA PET to see if it can find cancer that has spread to lymph nodes or other parts of the body, which standard scans often miss. The goal is to create a model that combines routine test results to predict who might have hidden cancer, helping doctors make better treatment decisions.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could help doctors better identify which high-risk prostate cancer patients have hidden cancer spread, leading to more personalized and effective treatment plans.
- What could go wrong
- This is an observational study, not a treatment trial, so it won't directly improve outcomes. The results may not apply to all patients or healthcare settings.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HIGH RISK PROSTATE CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a new tracer light up hidden prostate cancer?
- Could deep breaths before surgery ward off Post-Op confusion?
- A second look: MRI screening may spot hidden prostate cancers
- Can precision protons spare the bowel in prostate cancer?
- AI coaches doctors on cancer risk talks
- Can an immune booster make hormone therapy work better against prostate cancer?